Élisabeth focuses mainly on regulatory commercial matters, technology law and data protection. She provides advice on consumer, advertising and marketing law, including online sales and e-commerce.
Prior to joining BLG, Élisabeth worked in private practice, helping clients on a variety of issues in relation to intellectual property, privacy, technology and domain name management.
As part of her academic career, she worked as a research assistant in intellectual property financing and as coordinator of a university research project on technological evidence.
Experience
- COSCIENS Biopharma Inc., a publicly traded biopharmaceutical company, in its US$15-million acquisition of Nualtis Corp., a specialty pharmaceutical business focused on proprietary oral thin-film drug delivery technologies.
- Canadian counsel to KDDI Corporation in its approximately US$65 million minority investment in, and business alliance with, Coincheck Group N.V.
- COSCIENS Biopharma Inc., a publicly traded biopharmaceutical company, in its US$15-million acquisition of Nualtis Corp., a specialty pharmaceutical business focused on proprietary oral thin-film drug delivery technologies.
- Canadian counsel to KDDI Corporation in its approximately US$65 million minority investment in, and business alliance with, Coincheck Group N.V.